GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procyon Corp (OTCPK:PCYN) » Definitions » Financial Strength

PCYN (Procyon) Financial Strength : 7 (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Procyon Financial Strength?

Procyon has the Financial Strength Rank of 7.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

GuruFocus does not calculate Procyon's interest coverage with the available data. Procyon's debt to revenue ratio for the quarter that ended in Jun. 2024 was 0.06. As of today, Procyon's Altman Z-Score is 1.92.


Competitive Comparison of Procyon's Financial Strength

For the Drug Manufacturers - Specialty & Generic subindustry, Procyon's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procyon's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procyon's Financial Strength distribution charts can be found below:

* The bar in red indicates where Procyon's Financial Strength falls into.


;
;

Procyon Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Procyon's Interest Expense for the months ended in Jun. 2024 was $0.00 Mil. Its Operating Income for the months ended in Jun. 2024 was $0.01 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.14 Mil.

Procyon's Interest Coverage for the quarter that ended in Jun. 2024 is

GuruFocus does not calculate Procyon's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Procyon Corp has enough cash to cover all of its debt. Its financial situation is stable.

2. Debt to revenue ratio. The lower, the better.

Procyon's Debt to Revenue Ratio for the quarter that ended in Jun. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.181 + 0.139) / 5.652
=0.06

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Procyon has a Z-score of 1.92, indicating it is in Grey Zones. This implies that Procyon is in some kind of financial stress. If it is below 1.81, the company may faces bankrupcy risk.

Warning Sign:

Altman Z-score of 1.92 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Procyon  (OTCPK:PCYN) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Procyon has the Financial Strength Rank of 7.


Procyon Financial Strength Related Terms

Thank you for viewing the detailed overview of Procyon's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Procyon Business Description

Traded in Other Exchanges
N/A
Address
164 Douglas Road, Oldsmar, FL, USA, 34677
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
Executives
Foundation Speer 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Suggs Fred Wilson Jr director 60 FOREST LANE, GREENVILLE SC 29605
Steven Mccomas director 800 LASTAHOUSE DRIVE, VIDALIA GA 30474
Monica Mccullough director 1095 55TH TERR SO, SAINT PETERSBURG FL 33705
Joseph Raymond Treshler director PO BOX 5719, CLEARWATER FL 33758
George Otis Borak officer: Vice President 3300 COVE CAY DR, UNIT 7D, CLEARWATER FL 33760
Lynnda L Speer 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Richard M. Speer 10 percent owner 104 WOODMONT BOULEVARD, SUITE 415, NASHVILLE TN 37205
Speer Roy M Foundation 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Paul Edward Kudelko director 28 WINSTON DR, BELLEAIR FL 33756
Justice Wolfe Anderson director, officer: VP-Sales and Marketing 1300 S HIGHLAND AVE, CLEARWATER FL 33756
Regina Wolfe Anderson director 1300 S HIGHLAND AVE, CLEARWATER FL 33756
Jeffrey S Slowgrove director C/O INFORMATION MANAGEMENT RESOURCES INC, 26750 US HIGHWAY N #500, CLEARWATER FL 34621
John C Anderson Trust 10 percent owner 440 S GULFVIEW BLVD, APT 1702N, CLEARWATER FL 33767
Michael Timothy Foley director 2284 KINGS POINT DRIVE, LARGO FL 33774

Procyon Headlines

No Headlines